fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

FDA approval for Lenmeldy (atidarsagene autotemcel), to treat early-onset metachromatic leukodystrophy – Orchard Therapeutics

Written by | 22 Mar 2024

– Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, announced the FDA has… read more.

Multisite clinical trial will compare three FDA-approved drugs for Rett syndrome treatment

Written by | 5 Feb 2024

Vanderbilt University Medical Center received a $13 million Department of Defense grant to lead a multisite clinical trial that will evaluate repurposed FDA-approved drugs as treatment options for… read more.

Genetics links endometriosis and IBS

Written by | 29 Oct 2023

University of Queensland researchers have shown that endometriosis and irritable bowel syndrome (IBS) share genetic risk factors, explaining why patients with one condition may also have the other…. read more.

Study reveals average age at conception for men versus women over past 250,000 years

Written by | 11 Jan 2023

The length of a specific generation can tell us a lot about the biology and social organization of humans. Now, researchers at Indiana University can determine the average… read more.

Newly discovered gene promotes muscle strength

Written by | 30 Jul 2022

Researchers have identified a gene that promotes muscle strength when switched on by physical activity, unlocking the potential for the development of therapeutic treatments to mimic some of… read more.

One in 500 men carry extra sex chromosome, putting them at higher risk of several common diseases

Written by | 1 Jul 2022

Around one in 500 men could be carrying an extra X or Y chromosome — most of them unaware — putting them at increased risk of diseases such… read more.

Bioprinting for bone repair improved with genes

Written by | 17 Apr 2022

Given enough time and energy, the body will heal, but when doctors or engineers intervene, the processes do not always proceed as planned because chemicals that control and… read more.

Largest genetic study of migraine to date reveals new genetic risk factors

Written by | 10 Feb 2022

An international consortium of leading migraine scientists identified more than 120 regions of the genome that are connected to risk of migraine. The groundbreaking study helps researchers better… read more.

NICE (UK) recommends Adakveo as a treatment for preventing recurrent sickle cell crises – Novartis

Written by | 29 Oct 2021

Novartis is pleased to announce that eligible patients in England and Wales will soon have routine access to Adakveo (crizanlizumab) under a Managed Access Agreement (MAA). The news… read more.

Our genes shape our gut bacteria, new research shows

Written by | 17 Aug 2021

Our gut microbiome — the ever-changing “rainforest” of bacteria living in our intestines — is primarily affected by our lifestyle, including what we eat or the medications we… read more.

Nearly one in five patients who die from unexplained sudden cardiac death have suspicious gene, study finds

Written by | 2 Jul 2021

“Genetic screening isn’t routinely used in cardiology, and far too many patients still die suddenly from a heart condition without having any previously established risk factors. We need… read more.

Genetic screening before prescribing could benefit millions

Written by | 6 Feb 2021

Four million UK patients could benefit annually from genetic testing before being prescribed common medicines, according to new research from the University of East Anglia (UEA) in collaboration… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.